Predictive Models for Regional Hepatic Function Based on 99mTc-IDA SPECT and Local Radiation Dose for Physiologic Adaptive Radiation Therapy
Creators
- 1. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan (United States)
- 2. Department of Radiology, University of Michigan, Ann Arbor, Michigan (United States)
- 3. Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan (United States)
Description
Purpose: High-dose radiation therapy (RT) for intrahepatic cancer is limited by the development of liver injury. This study investigated whether regional hepatic function assessed before and during the course of RT using 99mTc-labeled iminodiacetic acid (IDA) single photon emission computed tomography (SPECT) could predict regional liver function reserve after RT. Methods and Materials: Fourteen patients treated with RT for intrahepatic cancers underwent dynamic 99mTc-IDA SPECT scans before RT, during, and 1 month after completion of RT. Indocyanine green (ICG) tests, a measure of overall liver function, were performed within 1 day of each scan. Three-dimensional volumetric hepatic extraction fraction (HEF) images of the liver were estimated by deconvolution analysis. After coregistration of the CT/SPECT and the treatment planning CT, HEF dose–response functions during and after RT were generated. The volumetric mean of the HEFs in the whole liver was correlated with ICG clearance time. Three models, dose, priori, and adaptive models, were developed using multivariate linear regression to assess whether the regional HEFs measured before and during RT helped predict regional hepatic function after RT. Results: The mean of the volumetric liver HEFs was significantly correlated with ICG clearance half-life time (r=−0.80, P<.0001), for all time points. Linear correlations between local doses and regional HEFs 1 month after RT were significant in 12 patients. In the priori model, regional HEF after RT was predicted by the planned dose and regional HEF assessed before RT (R=0.71, P<.0001). In the adaptive model, regional HEF after RT was predicted by regional HEF reassessed during RT and the remaining planned local dose (R=0.83, P<.0001). Conclusions: 99mTc-IDA SPECT obtained during RT could be used to assess regional hepatic function and helped predict post-RT regional liver function reserve. This could support individualized adaptive radiation treatment strategies to maximize tumor control and minimize the risk of liver damage
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2013.04.007Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2013.04.007;
- PII
- S0360-3016(13)00397-0;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 86
- Journal Issue
- 5
- Journal Page Range
- p. 1000-1006
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45089079
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CLEARANCE; EXTRACTION; HALF-LIFE; HEALTH HAZARDS; IMAGES; INDOCYANINE GREEN; INJURIES; LIVER; MULTIVARIATE ANALYSIS; NEOPLASMS; PATIENTS; RADIATION DOSES; RADIOTHERAPY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TECHNETIUM 99
- Descriptors DEC
- AROMATICS; AZAARENES; AZOLES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; CONDENSED AROMATICS; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; DOSES; DYES; EMISSION COMPUTED TOMOGRAPHY; GLANDS; HAZARDS; HETEROCYCLIC COMPOUNDS; HOURS LIVING RADIOISOTOPES; INDICATORS; INDOLES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; MATHEMATICS; MEDICINE; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANIC SULFUR COMPOUNDS; ORGANS; PYRROLES; RADIOISOTOPES; RADIOLOGY; SEPARATION PROCESSES; STATISTICS; SULFONATES; TECHNETIUM ISOTOPES; THERAPY; TOMOGRAPHY; YEARS LIVING RADIOISOTOPES
Optional Information
- Copyright
- Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.